TuHURA Biosciences: Skin Pharm Launches New Aesthetic Clinic in Tampa
- Skin Pharm is opening its first Florida clinic in Tampa on August 21, 2025, expanding its national presence.
- The clinic will offer personalized cosmetic dermatology services, including skin care consultations and injectables.
- Founded by Maegan Griffin in 2017, Skin Pharm focuses on empowering clients through quality aesthetic care and personalized treatments.
Skin Pharm Expands Aesthetic Services with New Tampa Clinic
Skin Pharm, a modern beauty brand focused on aesthetic skin care and medical-grade products, is making a significant advancement in its national expansion by opening its first clinic in Florida, located in Tampa. Set to launch on August 21, 2025, this new location will be the brand's thirteenth clinic in the United States. The clinic, situated at 2907 W. Bay to Bay Blvd., Suite 302, is already accepting bookings through its website, skinpharm.com, providing local residents with immediate access to a variety of personalized cosmetic dermatology services.
The new Tampa clinic is designed to reflect both the coastal charm of Florida and Skin Pharm's chic aesthetic. The interiors, crafted by Nashville-based designer Mrs. Paranjape, feature creamy whites, airy neutrals, and light wood finishes, creating a welcoming atmosphere for clients seeking beauty and rejuvenation treatments. Skin Pharm will offer an array of services, including skin care consultations, injectables, and its signature Gold Infusion treatment, all aimed at delivering natural and expert-led results. This expansion not only enhances Skin Pharm’s service offerings but also reinforces its commitment to creating a supportive environment for individuals looking to enhance their skin confidence.
Founded in 2017 by nurse practitioner Maegan Griffin, Skin Pharm emerged to fill noticeable gaps in the cosmetic dermatology field. Griffin's vision centers around providing a clinic that delivers the quality care she herself desired as a patient. With a highly skilled team of nurse practitioners and physician assistants, Skin Pharm emphasizes innovative aesthetic skin care and facial rejuvenation techniques. As the brand grows, Griffin remains dedicated to empowering clients, ensuring that they feel confident in their own skin. The Tampa clinic represents a pivotal step in Skin Pharm's mission to broaden access to beauty and anti-aging services across the region.
In addition to the upcoming Tampa clinic, Skin Pharm's national expansion underscores a growing trend in the beauty industry towards personalized and medically-informed aesthetic treatments. As consumers increasingly seek tailored solutions for their skin care needs, brands like Skin Pharm are well-positioned to meet this demand through their focus on quality and patient-centric care.
The clinic's opening is highly anticipated, with local residents eager to experience Skin Pharm's unique approach to cosmetic dermatology. As the beauty landscape continues to evolve, Skin Pharm's expansion signifies a notable commitment to enhancing the standards of aesthetic care and supporting individuals in their journey towards skin confidence.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

